These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 82539)

  • 1. Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease.
    Lange B; Arbeter A; Hewetson J; Henle W
    Int J Cancer; 1978 Nov; 22(5):521-7. PubMed ID: 82539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
    Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
    Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA).
    Lewin N; Aman P; Mellstedt H; Carenfelt C; Klein G; Klein E
    Anticancer Res; 1990; 10(5A):1213-6. PubMed ID: 2173472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous reactivation of Epstein-Barr virus infections.
    Sumaya CV
    J Infect Dis; 1977 Mar; 135(3):374-9. PubMed ID: 191540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings.
    Evans AS; Gutensohn NM
    Int J Cancer; 1984 Aug; 34(2):149-57. PubMed ID: 6088401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.
    Rocchi G; Tosato G; Papa G; Ragona G
    Int J Cancer; 1975 Aug; 16(2):323-8. PubMed ID: 168161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The seroepidemiology of infection due to Epstein-Barr virus in southern India.
    Venkitaraman AR; Lenoir GM; John TJ
    J Med Virol; 1985 Jan; 15(1):11-6. PubMed ID: 2981976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives.
    Besson C; Amiel C; Le-Pendeven C; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Abel L; Nicolas JC
    J Clin Microbiol; 2006 Jan; 44(1):47-50. PubMed ID: 16390946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between Epstein-Barr virus antibodies and clinical symptomatology and immunodeficiency in patients with Hodgkin's disease.
    Mochanko K; Fejes M; Breazavscek DM; Suarez A; Bachmann AE
    Cancer; 1979 Dec; 44(6):2065-70. PubMed ID: 228834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated antibody pattern in untreated non-Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions.
    Lindemalm C; Biberfeld P; Björkholm M; Henle G; Henle W; Holm G; Johansson B; Klein G; Mellstedt H
    Int J Cancer; 1983 Dec; 32(6):675-82. PubMed ID: 6317577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.
    Mueller N; Evans A; Harris NL; Comstock GW; Jellum E; Magnus K; Orentreich N; Polk BF; Vogelman J
    N Engl J Med; 1989 Mar; 320(11):689-95. PubMed ID: 2537928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral antibodies in the sera of homosexual men: correlation with their lifestyle and drug usage.
    Nerurkar LS; Biggar RJ; Goedert JJ; Wallen W; Becker P; West F; Tzan N; Traub R; Lee YJ; Botelar W
    J Med Virol; 1987 Feb; 21(2):123-35. PubMed ID: 3029318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus infections in Brazil. II. Hodgkin's disease.
    Evans AS; Carvalho RP; Frost P; Jamra M; Pozzi DH
    J Natl Cancer Inst; 1978 Jul; 61(1):19-26. PubMed ID: 209202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia.
    Sakamoto K; Aiba M; Katayama I; Sullivan JL; Humphreys RE; Purtilo DT
    Int J Cancer; 1981; 27(4):453-8. PubMed ID: 6268553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.